Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact Us
Search
Close
Enter Search Terms
Search
David Yi
ID:
1b839951-2619-30fb-68c4
/
Claimed Record
/
Organization:
Norton Rose Fulbright
Published Works
30 articles
Federal Court of Appeal upholds one of the last prohibition orders under the old PM(NOC) Regulations
Pharma in Brief ·
March 9, 2021
cite
Federal Court determines that infringement action under PM(NOC) Regulations is not moot where trial proceeds after patent expiry
Pharma in Brief ·
June 8, 2020
cite
Two PM(NOC) Actions Dismissed After Common Trial on Validity of Treatment Regimen Patent
Pharma in Brief ·
June 1, 2020
cite
Update: Expanded Federal Funding for Research and Innovation
Pharma in Brief ·
April 26, 2020
cite
Federal Court issues first decision on patent term restoration – Minister’s decision denying certificate of supplementary protection (CSP) is unreasonable
Pharma in Brief ·
April 8, 2020
cite
Previous
1
2
3
4
5
6
Next
Practice Areas
Health Care and Life Sciences
Jurisdictions
Canada
North America
